Posted by Michael Wonder on 04 Sep 2019
Releasing the potential of real world evidence
4 September 2019 - Janssen believes RWE could realise an efficient, personalised and truly patient-centric health care system.
Every day, everything we do generates an enormous amount of data. How best to analyse all this data and release the full potential of the insights it can offer is an issue the healthcare system is still struggling to work out.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, we want to improve health outcomes by translating large-scale real world data (RWD) into evidence, and then using that evidence in an open and transparent manner to complement the results of randomised controlled trials (RCTs).
